Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 120 (3) , 331-340
- https://doi.org/10.1016/0009-8981(82)90374-6
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Segregation within a family of two mutant alleles for hexosaminidase AClinical Genetics, 2008
- Biochemistry and Genetics of gangliosidosesHuman Genetics, 1979
- GM1-ganglioside β-galactosidase in leukocytes and cultured fibroblastsClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Ganglioside GM2 N‐acetyl‐ß‐D‐gafactosaminidase and asialo GM2 (GA2) N‐acetyl‐ß‐D‐galactosaminidase; studies in human skin fibroblastsClinical Genetics, 1977
- Neuraminic acid-specific modification and tritium labelling of gangliosidesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Separation of three isoenzymes of N-acetyl-β-D-hexosaminidase from human tissues by cellulose acetate membrane electrophoresisJournal of Clinical Pathology, 1974
- The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissueJournal of Clinical Investigation, 1972
- Lactosylceramide galactosidase: Comparison with other sphingolipid hydrolases in developing rat brainBrain Research, 1969
- Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-β-glucosaminidaseBiochemical Journal, 1961
- Quantitive estimation of sialic acidsBiochimica et Biophysica Acta, 1957